PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity (Q31111090)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity
scientific article

    Statements

    PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity (English)
    Patricio Oyarzún
    Jonathan J Ellis
    14 February 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit